P78 Patients over 80 years of age with de novo AML, normal karyotype, and without erythroblastic and/or megakaryocytic dysplasia may reach complete remission and better survival after standard dose chemotherapy

Saved in:
Bibliographic Details
Published in:Critical reviews in oncology/hematology 2009, Vol.72 (1), p.S46-S47
Main Authors: Lemez, P, Galikova, J, Michalova, K, MacWhannell, A, Dvorakova, D, Zemanova, Z, Stejskal, J
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1040-8428
1879-0461
DOI:10.1016/S1040-8428(09)70116-7